H.R. 6, H.R. 34 & Public Law 114-255, 21st Century Cures Act; 
S. 2700, FDA and NIH Workforce Authorities Modernization Act;
H.R. 3381, Childhood Cancer STAR Act;
Discussions to clarify or reform the 340B program; 
Biologics Price Competition and Innovation Act; 
Public Law 111-148, The Patient Protection and Affordable Care Act; 
Public Law 111-152, The Health Care and Education Reconciliation Act;
H.R. 2228 & S.122, Safe and Affordable Drugs from Canada Act of 2015; 
Proposals to address prescription drug abuse; 
Implementation/Reauthorization of The Prescription Drug User Fee Act (PDUFA); 
Implementation/Reauthorization of The Biosimilars User Fee Act (BsUFA); 
H.R. 639 & S. 481, Improving Regulatory Transparency for New Medical Therapies;
H.R. 2570 & S. 1396, Value-Based Insurance Design Seniors Copayment Reduction Act of 2015; 
H.R. 3012 & S. 2912, Trickett Wendler Right to Try Act of 2016;
H.R. 6043 & S. 3335, Fair Accountability and Innovative Research Drug Pricing Act of 2016; 
S.3239, RACE for Children Act;
Expanded Access (legislation not introduced)
H.R. 4207, Medicare Fair Drug Pricing Act of 2015;
Clinton's 1993 Health Security Act; 
S. 2023, Prescription Drug Affordability Act of 2015;
H.R. 6501, Prescription Drug and Medical Device Price Review Board Act of 2016; 
S.3455, Pharmaceutical Supply and Value Enhancement Act; 
Repeal and Replace Proposals for Public Law 111-148, The Patient Protection and Affordable Care Act (no legislation introduced); Policies to enhance patient access to medicines in Medicaid;
Policies to enhance patient access to medicines in Medicare; 
H.R. 3061 & S. 31, Medicare Prescription Drug Price Negotiation Act of 2015; 
H.R. 2005 & S. 1083, Medicare Drug Savings Act;
H.R. 5122, To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models;
Medicare payment proposals (MedPAC);
Medicare Access and CHIP Reauthorization Act (MACRA); S. 632, STRONG Patents Act of 2015;
S. 2733, Venue Equity and Non-Uniformity Elimination Act of 2016;
H.R. 5573 & S. 3094, Price Relief, Innovation, and Competition for Essential Drugs (PRICED) Act;
S. 3056, CREATES Act of 2016; 
Proposals/Initiatives related to international intellectual property protection; H.R. 2028 & Public Law 114-254, Further Continuing and Security Assistance Appropriations Act, 2017;
Other Labor, Health and Human Services Appropriations (no bills introduced);
S. 1413, FDA User Fee Protection Act; Trans-Atlantic Trade and Investment Partnership; 
Trans-Pacific Partnership Agreement; 
Japan Pricing and Regulatory Issues;
Egypt Exchange Rate and Pricing Issues;
Colombia Potential Compulsory Licensing Issue; Senate and House Committee Tax Reform Proposals; 
H.R. 5278, PROMESA;
Puerto Rican Economy and Debt Relief Proposals (no bills introduced);
Proposals to reform domestic and international tax structures (no bills introduced);
HCR - Health Issues MMM - Medicare/Medicaid CPT - Copyright/Patent/Trademark BUD - Budget/Appropriations TRD - Trade (domestic/foreign) TAX - Taxation/Internal Revenue Code
136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR) 136 - Centers For Medicare and Medicaid Services (CMS) 24 - Commerce, Dept of (DOC) 137 - Health Resources & Services Administration (HRSA) 2 - HOUSE OF REPRESENTATIVES 253 - Medicare Payment Advisory Commission (MedPAC) 113 - Patent & Trademark Office (PTO) 1 - SENATE 39 - State, Dept of (DOS) 22 - U.S. Trade Representative (USTR)
ABBVIE, INC.
1399 New York Avenue NW, Suite 600, Washington, DC, 20005, US
MICHAEL D BOYD JOHN P. FORD HEATHER STRAWN STEPHEN SCANGO DANIEL BACHNER JOHN P. FORD HEATHER STRAWN MICHAEL D BOYD STEPHEN SCANGO DANIEL BACHNER HEATHER STRAWN MICHAEL D BOYD DANIEL BACHNER JOHN P. FORD HEATHER STRAWN MICHAEL D BOYD DANIEL BACHNER STEPHEN SCANGO MICHAEL D BOYD HEATHER STRAWN MICHAEL D BOYD HEATHER STRAWN JOHN P. FORD DANIEL BACHNER STEPHEN SCANGO